4D Molecular Therapeutics Announces Updates on Clinical Pipeline and Additional Preclinical Programs

(marketscreener.com) Expands Large Market Ophthalmology Portfolio Following Positive Clinical Data in wet Age-Related Macular Degeneration to Include Diabetic Macular Edema Clinical Program and Geographic Atrophy Preclinical ProgramExpands Large Market Pulmonology Portfolio Following Positive Clinical Data in Cystic Fibrosis to Include Alpha-1 Antitrypsin Deficiency...https://www.marketscreener.com/quote/stock/4D-MOLECULAR-THERAPEUTICS-116373767/news/4D-Molecular-Therapeutics-Announces-Updates-on-Clinical-Pipeline-and-Additional-Preclinical-Programs-42692983/?utm_medium=RSS&utm_content=20230109...